Last reviewed · How we verify
NCT05199155
Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist
Phase 2 trial testing NerVFIX in Nerve Injury in 12 participants. Terminated before completion.
13 August 2024
Quick facts
| Lead sponsor | TBF Genie Tissulaire |
|---|---|
| Phase | Phase 2 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 8 December 2020 |
| Primary completion | 13 August 2024 |
| Estimated completion | 13 August 2024 |
| Sites | 2 locations across France |
Drugs / interventions tested
- NerVFIX — full drug profile →
Conditions studied
- Nerve Injury — all drugs for Nerve Injury →
- Nerve Lesion — all drugs for Nerve Lesion →
Sponsor
TBF Genie Tissulaire — full company profile →
Who can join
Adults 18 to 65, any sex, with Nerve Injury or Nerve Lesion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this open, multicenter trial is to assess the impact of a nerve regeneration conduit made of allogeneic artery or vein from umbilical cord lining on the regeneration of wrist nerve.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Engineering neural recovery: Micro/nano-structured materials for nerve regeneration.
Zhang H, Sha J, Cao S, Feng J, et al · · 2025 · cited 1× · PMID 41322153 · DOI 10.1016/j.mtbio.2025.102538
Verify or expand the search:
- PubMed search for NCT05199155
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nerve Injury
Currently open trials in the same condition.
- NCT07084207 — A Study to Expand the Use of Symani® Surgical System for Peripheral Nerve Repair · NA · recruiting
- NCT05365282 — Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study · recruiting
- NCT05593237 — Transcranial Magnetic Stimulation for Chronic Neuropathic Pain · NA · active not recruiting
- NCT04144972 — Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain · NA · recruiting
Other TBF Genie Tissulaire trials
Trials by the same sponsor.
- NCT05638139 — Treatment of Ano-perineal Fistulas Resistant to Surgical Treatment with a Gel and Plug of Wharton's Jelly · Phase 1 · completed
- NCT05302609 — Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface · Phase 2 · terminated
- NCT05247658 — Use of a Disk of Amniotic Membrane (Visio-AMTRIX) in Postoperative Care After PKR · Phase 3 · terminated
- NCT05207189 — Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Comp · Phase 2 · completed
- NCT05250726 — Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoa · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05199155 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TBF Genie Tissulaire
- Last refreshed: 14 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05199155.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing